Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03407638 · ClinicalTrials.gov registry record · NA
PRimary Care Opioid Use Disorders Treatment (PROUD) Trial
A NA study of Opioid Use Disorder, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 973,759
- Enrollment target
- 6
- Study locations
NCT03407638 is a NA study of Opioid Use Disorder that has completed, run by Kaiser Permanente. The registered enrollment target is 973,759 participants, above the 867-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (112214% higher). The trial reports 6 study locations across 5 states.
The verdict
NCT03407638, a NA study of Opioid Use Disorder, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 973,759 participants
- Enrollment target
- 6
- Study locations
Study Summary
Effective treatment for opioid use disorders (OUDs) requires medications. Two medications for treating OUDs-buprenorphine and injectable naltrexone-can be prescribed in primary care (PC). However, despite the current opioid epidemic and expert recommendations that OUDs should be treated in PC, most PC clinics do not offer treatment for OUDs. This reflects a lack of consensus among health system leaders and clinicians that OUDs should be treated in PC. The PRimary care Opioid Use Disorders treatment (PROUD) Trial is a pragmatic cluster-randomized, quality improvement trial that evaluates implementation of a team-based approach to PC supported by a full time nurse (the "PROUD intervention"). This type of team-based PC is often referred to as "collaborative care" for management of OUDs in PC, and this type of trial is often referred to as a Hybrid Type III implementation trial. The trial is being conducted in 6 diverse health systems spanning 5 states (New York, Florida, Michigan, Texas, and Washington), with 2 PC clinics in each system randomized. One clinic is randomly selected to implement the PROUD intervention and the other continues usual PC (UPC). The overall objective of the PROUD trial is to provide information to guide health system leaders who are faced with the decision of whether or not to treat OUDs in PC, by evaluating the benefits of implementing the PROUD intervention that integrates high quality OUD treatment (i.e. buprenorphine or injectable naltrexone) into the normal flow of PC. The primary objective of the PROUD trial is to evaluate whether the PROUD intervention increases OUD treatment with buprenorphine or injectable naltrexone, documented in the electronic health records (EHRs) of PC patients, over a 2 year follow-up, as compared to UPC. The primary hypothesis is that there will be a significant increase in the number of patient-days of medication treatment for OUDs documented in the EHR of PC patients in the 2 years after clinics are rand
Conditions Studied
Interventions
- OTHER PROUD Intervention
Study Locations (6)
Washington
- Kaiser Permanente Washington - Seattle
- MultiCare Health System - Tacoma
Florida
- University of Miami Health System - Miami
Michigan
- Henry Ford Health System - Detroit
New York
- Montefiore Medical Center - The Bronx
Texas
- Harris Health System - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 973,759 participants |
| Start Date | 2018-02-28 |
| Est. Completion | 2020-02-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03407638
The ClinicalTrials.gov registry entry for NCT03407638 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 973,759 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 867-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (112214% higher). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which PROUD Intervention is the first listed.
NCT03407638 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Washington, Florida, Michigan.
Frequently Asked Questions
What is clinical trial NCT03407638 about?
NCT03407638 is a clinical study titled "PRimary Care Opioid Use Disorders Treatment (PROUD) Trial". Effective treatment for opioid use disorders (OUDs) requires medications. Two medications for treating OUDs-buprenorphine and injectable naltrexone-can be prescribed in primary care (PC). However, despite the current opioid epidemic and expert recommendations that OUDs should be treated in PC, most ...
What is the current status of trial NCT03407638?
This trial is currently completed. It is a NA study. The enrollment target is 973,759 participants. The study started on 2018-02-28. Estimated completion is 2020-02-29.
What conditions does trial NCT03407638 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT03407638?
The interventions under investigation include: PROUD Intervention (OTHER).
Who is sponsoring clinical trial NCT03407638?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03407638 being conducted?
This trial has 6 study locations across Florida, Michigan, New York, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.